Sign in
Taking peopleNo phase

Tendyne European Experience Registry

Key facts

Who runs it
LMU Klinikum
Where
Austria, Belgium, France, Germany, Italy, Norway, Spain, Sweden, Switzerland, and United Kingdom30 sites in 10 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
400 people, planned
Started
15 Apr 2021
Expected to end
31 Dec 2027
Type of study
Observational
Treatments tested
  • Tendyne Mitral Valve System
Record updated
24 May 2021

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients treated with the Tendyne Mitral Valve System for mitral valve disease in a commercial setting
  • Patients providing written informed consent in compliance with the protocol, the ICH-GCP and all national legal and regulatory requirements

Who cannot take part

  • Patients not providing written informed consent

This trial has no sites in United States.

It has sites in 10 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.

The group in the trial

  • Tendyne

    all patients treated with a Tendyne Mitral Valve System

    Treatment: Tendyne Mitral Valve System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
TENDyne European expeRience Registry
Publications
Record updated
24 May 2021